PATENT CLAIM ANALYSIS

Application Number: 15770737
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "356000"]

Abstract:
The present specification provides methods of treating nervous system disorders with a thyroid hormone neutral dose of a RXR agonist to promote remyelination or neuroprotection or both and thereby maintain or regenerate healthy axons and neurons.

Claim (Index 6):
The method according to  claim 1 , wherein the dose of RXR agonist in step (b) is about 0.001 mg/day to about 1000 mg/day.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15812821', '15339752', '15339762', '14507730', '10477876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8599146024659765
- 35 USC 102 Novelty (BERT): 0.6251698183948162
- Combined Prediction Score: 0.8364401240588605
- Mean Citation Score: 525.456226
- Max Citation Score: 623.54266
- Similarity Product: 476.737921912334

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test